Delivery Order SPE2DB22D2214-SPE2DB25FS2UH

Award Date 11/14/24
Potential Completion Date 11/15/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS2UH
    Delivery Order

This federal contract award, with ID SPE2DB22D2214|SPE2DB25FS2UH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, has a firm fixed price and a ceiling value of $1,005.45. It is for the supply of Lyrica 100 mg capsules, a medication used for various conditions. The contract has an ultimate completion date of November 15, 2024 and was awarded on November 14, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/13/25, 9:37 AM